Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice. - Wikidata - awgldk - TriplyDB

Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.

Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.

http://www.wikidata.org/entity/Q35995921

about

Angiopoietin-Tie signalling in the cardiovascular and lymphatic systems Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice The therapeutic effect of bevacizumab on plaque neovascularization in a rabbit model of atherosclerosis during contrast-enhanced ultrasonography.In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued Angiogenesis in the atherosclerotic plaque.Therapeutic targeting of the angiopoietin-TIE pathway.Evaluation of Carotid Plaque Neovascularization in Patients With Coronary Heart Disease on Contrast-Enhanced Ultrasonography.Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.

P2860

Q28070234-23298D7E-8466-4A8D-83F1-9864AF43C81D Q28383906-8958642F-4743-4A97-B662-C71453D6907B Q30377223-067CBED7-EBFA-49F5-A608-66CF42161567 Q36149661-7704281B-E4A2-4797-80EA-E4DBB1725476 Q37645436-C96620B4-7F86-41B6-8920-68EDAD107DE2 Q39321127-451B83C3-B1A4-47D9-B861-6F533C6D1499 Q47658676-90799F14-C620-4557-9F04-9F59844E2B07 Q55087013-509E0EA9-2C43-455C-A68A-6BEBF0A6C543

P2860

Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.

http://www.wikidata.org/entity/Q35995921

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Angiopoietin-2 blocking antibo ...... ic plaque development in mice.

@ast

Angiopoietin-2 blocking antibo ...... ic plaque development in mice.

@en

type

label

Angiopoietin-2 blocking antibo ...... ic plaque development in mice.

@ast

Angiopoietin-2 blocking antibo ...... ic plaque development in mice.

@en

prefLabel

Angiopoietin-2 blocking antibo ...... ic plaque development in mice.

@ast

Angiopoietin-2 blocking antibo ...... ic plaque development in mice.

@en

P1433

Q35995921-828A6325-D6DA-4B87-8F7D-882803E9F40E

P1476

Q35995921-E9184B69-A1FF-4E84-86D4-47A535E3441A

P2093

Q35995921-0A9C145E-B6DF-4C18-A7E2-EC663713D382

Q35995921-32C726E2-928B-4F1B-98EE-BFEA835DD65E

Q35995921-91EE7F0A-D19D-412D-9148-990033C67A7E

Q35995921-B4450766-9E00-4126-8385-41321BF3E112

Q35995921-F1A66E5B-9136-4A7E-936B-7F4F5FA5EAFC

Q35995921-F7809B68-1DA4-4246-B5D3-46DEFF5F943B

P2860

Q35995921-0DA58E03-4841-4AAE-AADB-2E40798456A7

Q35995921-16393E1B-13A0-47AC-974D-DEFDE9DE9EDF

Q35995921-2599F8D0-82CE-4971-B179-D15D5376040D

Q35995921-260AB01C-6479-42E2-AAF3-6E9B32168186

Q35995921-26F9AC46-6AF1-4D37-9B7E-864789514642

Q35995921-27D69723-A42E-4960-BD46-3C561700708B

Q35995921-3FEB7B7E-8159-48CB-B5FF-EAE31B43C42E

Q35995921-40BE45DE-F27B-4ADC-926C-895FD0E3345A

Q35995921-4261E92D-B9EF-4603-AD8D-61CC13B99F44

Q35995921-43287C2D-95B5-402D-9410-EAD881D362A4

P304

Q35995921-D6203EDF-DEB2-4A2C-A0B4-DBC42A9C61AB

P31

Q35995921-647E4C24-7D28-449C-96D7-072E4ABE5451

P356

Q35995921-10E75D1E-6C0D-4E7F-98BD-A1396677609B

P433

Q35995921-4E6C7E45-3509-4F7F-A1AA-F4FA73A01EB5

P478

Q35995921-FE4FAD52-28AB-40E9-8A77-3F855B92D0A3

P50

Q35995921-0D2B468F-D4F3-4C15-B1ED-C12C5A7DBCD7

Q35995921-642065D5-AE2C-4A49-B351-0995ADF6E1DF

Q35995921-909AC20C-EDE8-4A2C-9AAF-E77441745173

Q35995921-A0B922E2-2EA2-4DB7-9C11-579605611C20

P577

Q35995921-37F12625-997F-4A87-89E5-EFE51B5049FE

P698

Q35995921-23B16822-BB41-4D90-A1E5-59F96DC8FC7E

P921

Q35995921-2C7714ED-AEDE-4565-897F-E9207FAC5A6B

P932

Q35995921-B8931B4B-4777-4762-B83C-527D2B69CB4B

P356

J.ATHEROSCLEROSIS.2015.05.018

P1433

Atherosclerosis

P1476

Angiopoietin-2 blocking antibo ...... ic plaque development in mice.

@en

P2093

Erik A L Biessen

http://www.w3.org/2001/XMLSchema#string

Erika Gurzeler

http://www.w3.org/2001/XMLSchema#string

Jack P Cleutjens

http://www.w3.org/2001/XMLSchema#string

Jari P Lappalainen

http://www.w3.org/2001/XMLSchema#string

Marion J Gijbels

http://www.w3.org/2001/XMLSchema#string

Thomas L Theelen

http://www.w3.org/2001/XMLSchema#string

P2860

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation

Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis

Hemodynamics in the mouse aortic arch as assessed by MRI, ultrasound, and numerical modeling.

Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study

Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo.

Angiopoietin-2 confers Atheroprotection in apoE-/- mice by inhibiting LDL oxidation via nitric oxide.

Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.

Angiopoietin-2 is critical for cytokine-induced vascular leakage

P304

297-304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ATHEROSCLEROSIS.2015.05.018

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

241

http://www.w3.org/2001/XMLSchema#string

P50

Seppo Ylä-Herttuala

Judith C Sluimer

Mat J A P Daemen

P577

2015-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26062989

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

4549395

http://www.w3.org/2001/XMLSchema#string